Success Metrics

Clinical Success Rate
90.2%

Based on 37 completed trials

Completion Rate
90%(37/41)
Active Trials
19(26%)
Results Posted
57%(21 trials)
Terminated
4(6%)

Phase Distribution

Ph phase_1
16
22%
Ph phase_2
17
24%
Ph phase_3
11
15%
Ph phase_4
14
19%
Ph not_applicable
13
18%
Ph early_phase_1
1
1%

Phase Distribution

17

Early Stage

17

Mid Stage

25

Late Stage

Phase Distribution72 total trials
Early Phase 1First-in-human
1(1.4%)
Phase 1Safety & dosage
16(22.2%)
Phase 2Efficacy & side effects
17(23.6%)
Phase 3Large-scale testing
11(15.3%)
Phase 4Post-market surveillance
14(19.4%)
N/ANon-phased studies
13(18.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

86.0%

37 of 43 finished

Non-Completion Rate

14.0%

6 ended early

Currently Active

19

trials recruiting

Total Trials

72

all time

Status Distribution
Active(29)
Completed(37)
Terminated(6)

Detailed Status

Completed37
Recruiting16
Not yet recruiting10
Terminated4
Active, not recruiting3
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
72
Active
19
Success Rate
90.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (1.4%)
Phase 116 (22.2%)
Phase 217 (23.6%)
Phase 311 (15.3%)
Phase 414 (19.4%)
N/A13 (18.1%)

Trials by Status

recruiting1622%
terminated46%
active_not_recruiting34%
completed3751%
withdrawn23%
not_yet_recruiting1014%

Recent Activity

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more
NCT06339411Phase 2

Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy

Not Yet Recruiting
NCT06909565Phase 4

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Recruiting
NCT06217939Not Applicable

Early Intravenous Hydrocortisone in Sepsis

Terminated
NCT07714902Not Applicable

Administration Of Calcium Gluconate for The Reduction of Blood Loss During Vaginal Delivery

Recruiting
NCT07691684Not Applicable

Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement

Completed
NCT07658690Phase 3

Effectiveness of Single and Dual Silver Fluoride Application

Not Yet Recruiting
NCT07362992Early Phase 1

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

Recruiting
NCT06862453Phase 1

Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

Recruiting
NCT07415252Phase 3

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Not Yet Recruiting
NCT06958367Phase 1

Effect of Dexmedetomidine on Acute Kidney Injury After Ascending Aortic Surgeries

Active Not Recruiting
NCT04648774Not Applicable

Continuous Serratus Anterior Blockade for Sternotomy

Completed
NCT06546709Phase 1

DMID 23-0015; Lassa Fever CVD 1000

Active Not Recruiting
NCT07617675Phase 4

rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)

Not Yet Recruiting
NCT07617896Phase 2

Intravesical Aminophylline to Facilitate Ureteroscopic Access in Children With Distal Ureteral Stones.

Recruiting
NCT06828666Phase 1

A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee

Active Not Recruiting
NCT05873218Phase 4

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

Recruiting
NCT07570836Phase 1

Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease

Not Yet Recruiting
NCT07394036Phase 2

Effect of Ipratropium Bromide on EILO

Not Yet Recruiting
NCT06652737Phase 1

Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Completed
NCT07035301Not Applicable

Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures

Completed

Drug Details

Intervention Type
DRUG
Total Trials
72